Latest / Applied Clinical Trials
ACT Brief: Community Trial Cost Barriers, Measuring What Matters, and Prostate Cancer Approval
In today’s ACT Brief, we examine how cost barriers and site infrastructure limit participation in community trials, why endpoints should reflect what patients actually experience, and how the FDA expanded a prostate cancer combination to an earlier treatment setting.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.